Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Regenerative Medicines Sales Market Report 2021

  • QYR644878
  • 122 Pages
  • August 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
This report studies sales (consumption) of Regenerative Medicines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Celgene Corporation (U.S.)

StemCells, Inc. (U.S.)

Corning Incorporated (U.S.)

Organogenesis Inc. (U.S.)

Acelity (KCI Licensing) (U.S.)

Vertex Pharmaceuticals Incorporated (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Cell Therapy

Gene Therapy

Immunotherapy

Tissue Engineering

Split by applications, this report focuses on sales, market share and growth rate of Regenerative Medicines in each application, can be divided into

Department of orthopedics and musculoskeletal spine

Skin disease

Cardiovascular

Central nervous system

Oncology

Diabetes

Table of Contents

United States Regenerative Medicines Sales Market Report 2021

1 Regenerative Medicines Overview

1.1 Product Overview and Scope of Regenerative Medicines

1.2 Classification of Regenerative Medicines

1.2.1 Cell Therapy

1.2.2 Gene Therapy

1.2.3 Immunotherapy

1.2.4 Tissue Engineering

1.3 Applications of Regenerative Medicines

1.3.1 Department of orthopedics and musculoskeletal spine

1.3.2 Skin disease

1.3.3 Cardiovascular

1.3.4 Central nervous system

1.3.5 Oncology

1.3.6 Diabetes

1.4 USA Market Size (Value and Volume) of Regenerative Medicines (2011-2021)

1.4.1 USA Regenerative Medicines Sales, Revenue and Price (2011-2021)

1.4.2 USA Regenerative Medicines Sales and Growth Rate (2011-2021)

1.4.3 USA Regenerative Medicines Revenue and Growth Rate (2011-2021)

2 USA Regenerative Medicines Competition by Manufacturers

2.1 USA Regenerative Medicines Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Regenerative Medicines Revenue and Share by Manufactures (2015 and 2016)

3 USA Regenerative Medicines (Volume and Value) by Type

3.1 USA Regenerative Medicines Sales and Market Share by Type (2011-2021)

3.2 USA Regenerative Medicines Revenue and Market Share by Type (2011-2021)

4 USA Regenerative Medicines (Volume) by Application

5 USA Regenerative Medicines Manufacturers Analysis

5.1 Celgene Corporation (U.S.)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Regenerative Medicines Product Type and Technology

5.1.2.1 Cell Therapy

5.1.2.2 Gene Therapy

5.1.3 Regenerative Medicines Sales, Revenue, Price of Celgene Corporation (U.S.) (2015 and 2016)

5.2 StemCells, Inc. (U.S.)

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Pharmaceuticals Product Type and Technology

5.2.2.1 Cell Therapy

5.2.2.2 Gene Therapy

5.2.3 Pharmaceuticals Sales, Revenue, Price of StemCells, Inc. (U.S.) (2015 and 2016)

5.3 Corning Incorporated (U.S.)

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Corning Incorporated (U.S.) Product Type and Technology

5.3.2.1 Cell Therapy

5.3.2.2 Gene Therapy

5.3.3 Corning Incorporated (U.S.) Sales, Revenue, Price of Corning Incorporated (U.S.) (2015 and 2016)

5.4 Organogenesis Inc. (U.S.)

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Product Type and Technology

5.4.2.1 Cell Therapy

5.4.2.2 Gene Therapy

5.4.3 Organogenesis Inc. (U.S.) Sales, Revenue, Price of Organogenesis Inc. (U.S.) (2015 and 2016)

5.5 Acelity (KCI Licensing) (U.S.)

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Acelity (KCI Licensing) (U.S.) Product Type and Technology

5.5.2.1 Cell Therapy

5.5.2.2 Gene Therapy

5.5.3 Acelity (KCI Licensing) (U.S.) Sales, Revenue, Price of Acelity (KCI Licensing) (U.S.) (2015 and 2016)

5.6 Vertex Pharmaceuticals Incorporated (U.S.)

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 Vertex Pharmaceuticals Incorporated (U.S.) Product Type and Technology

5.6.2.1 Cell Therapy

5.6.2.2 Gene Therapy

5.6.3 Vertex Pharmaceuticals Incorporated (U.S.) Sales, Revenue, Price of Vertex Pharmaceuticals Incorporated (U.S.) (2015 and 2016)

6 Regenerative Medicines Technology and Development Trend

6.1 Regenerative Medicines Technology Analysis

6.2 Regenerative Medicines Technology Development Trend

7 Research Findings and Conclusion

List Of Tables and Figures

Figure Picture of Regenerative Medicines

Table Classification of Regenerative Medicines

Figure USA Sales Market Share of Regenerative Medicines by Type in 2015

Figure Cell Therapy Picture

Figure Gene Therapy Picture

Figure Immunotherapy Picture

Figure Tissue Engineering Picture

Table Applications of Regenerative Medicines

Figure USA Sales Market Share of Regenerative Medicines by Application in 2015

Figure Department of orthopedics and musculoskeletal spine Examples

Figure Skin disease Examples

Figure Cardiovascular Examples

Figure Central nervous system Examples

Figure Oncology Examples

Figure Diabetes Examples

Table USA Regenerative Medicines Sales, Revenue and Price (2011-2021)

Figure USA Regenerative Medicines Sales and Growth Rate (2011-2021)

Figure USA Regenerative Medicines Revenue and Growth Rate (2011-2021)

Table USA Regenerative Medicines Sales of Key Manufacturers (2015 and 2016)

Table USA Regenerative Medicines Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Regenerative Medicines Sales Share by Manufacturers

Figure 2016 Regenerative Medicines Sales Share by Manufacturers

Table USA Regenerative Medicines Revenue by Manufacturers (2015 and 2016)

Table USA Regenerative Medicines Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Regenerative Medicines Revenue Share by Manufacturers

Table 2016 USA Regenerative Medicines Revenue Share by Manufacturers

Table USA Regenerative Medicines Sales and Market Share by Type (2011-2021)

Table USA Regenerative Medicines Sales Share by Type (2011-2021)

Figure Sales Market Share of Regenerative Medicines by Type (2011-2021)

Figure USA Regenerative Medicines Sales Growth Rate by Type (2011-2021)

Table USA Regenerative Medicines Revenue and Market Share by Type (2011-2021)

Table USA Regenerative Medicines Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Regenerative Medicines by Type (2011-2021)

Figure USA Regenerative Medicines Revenue Growth Rate by Type (2011-2021)

Table USA Regenerative Medicines Sales and Market Share by Application (2011-2021)

Table USA Regenerative Medicines Sales Share by Application (2011-2021)

Figure Sales Market Share of Regenerative Medicines by Application (2011-2021)

Figure USA Regenerative Medicines Sales Growth Rate by Application (2011-2021)

Table Celgene Corporation (U.S.) Basic Information List

Table Regenerative Medicines Sales, Revenue, Price of Celgene Corporation (U.S.) (2015 and 2016)

Table StemCells, Inc. (U.S.) Basic Information List

Table Regenerative Medicines Sales, Revenue, Price of StemCells, Inc. (U.S.) (2015 and 2016)

Table Corning Incorporated (U.S.) Basic Information List

Table Regenerative Medicines Sales, Revenue, Price of Corning Incorporated (U.S.) (2015 and 2016)

Table Organogenesis Inc. (U.S.) Basic Information List

Table Regenerative Medicines Sales, Revenue, Price of Organogenesis Inc. (U.S.) (2015 and 2016)

Table Acelity (KCI Licensing) (U.S.) Basic Information List

Table Regenerative Medicines Sales, Revenue, Price of Acelity (KCI Licensing) (U.S.) (2015 and 2016)

Table Vertex Pharmaceuticals Incorporated (U.S.) Basic Information List

Table Regenerative Medicines Sales, Revenue, Price of Vertex Pharmaceuticals Incorporated (U.S.) (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390